Zhao Qi, Chen Yan-Yan, Xu Ding-Qiao, Yue Shi-Jun, Fu Rui-Jia, Yang Jie, Xing Li-Ming, Tang Yu-Ping
Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, and State Key Laboratory of Research and Development of Characteristic Qin Medicine Resources (Cultivation), and Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research, Shaanxi University of Chinese Medicine, Xi'an, China.
Front Pharmacol. 2021 Jul 27;12:630249. doi: 10.3389/fphar.2021.630249. eCollection 2021.
Chronic constipation is a common gastrointestinal disorder, with a worldwide incidence of 14-30%. It negatively affects quality of life and is associated with a considerable economic burden. As a disease with multiple etiologies and risk factors, it is important to understand the pathophysiology of chronic constipation. The purpose of this review is to discuss latest findings on the roles of gut motility, fluid, and electrolyte transport that contribute to chronic constipation, and the main drugs available for treating patients. We conducted searches on PubMed and Google Scholar up to 9 February 2021. MeSH keywords "constipation", "gastrointestinal motility", "peristalsis", "electrolytes", "fluid", "aquaporins", and "medicine" were included. The reference lists of searched articles were reviewed to identify further eligible articles. Studies focusing on opioid-induced constipation, evaluation, and clinic management of constipation were excluded. The occurrence of constipation is inherently connected to disorders of gut motility as well as fluid and electrolyte transport, which involve the nervous system, endocrine signaling, the gastrointestinal microbiota, ion channels, and aquaporins. The mechanisms of action and application of the main drugs are summarized; a better understanding of ion channels and aquaporins may be helpful for new drug development. This review aims to provide a scientific basis that can guide future research on the etiology and treatment of constipation.
慢性便秘是一种常见的胃肠道疾病,全球发病率为14%-30%。它对生活质量有负面影响,并伴有相当大的经济负担。作为一种具有多种病因和风险因素的疾病,了解慢性便秘的病理生理学很重要。本综述的目的是讨论肠道运动、液体和电解质转运在慢性便秘中所起作用的最新研究结果,以及治疗患者的主要可用药物。我们在截至2021年2月9日的PubMed和谷歌学术上进行了检索。纳入了医学主题词“便秘”“胃肠动力”“蠕动”“电解质”“液体”“水通道蛋白”和“药物”。对检索到的文章的参考文献列表进行了审查,以确定更多符合条件的文章。排除了专注于阿片类药物引起的便秘、便秘的评估和临床管理的研究。便秘的发生与肠道运动以及液体和电解质转运紊乱有着内在联系,这些紊乱涉及神经系统、内分泌信号、胃肠道微生物群、离子通道和水通道蛋白。总结了主要药物的作用机制和应用;更好地了解离子通道和水通道蛋白可能有助于新药研发。本综述旨在提供一个科学依据,以指导未来关于便秘病因和治疗的研究。